Wednesday, November 06, 2019 12:38:41 PM
As the only publicly traded company in America growing and processing hemp for CBD Isolate and selling a full lineup of Pure CBD Oil products using terpenes to create the entourage effect, CANB is best positioned to deliver a windfall to its investors due to the FDA permitting the national sales of Pure CBD products only
Mile High Labs and Medterra are two of the biggest CBD Isolate processors and Pure CBD Oil products companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to a fully vertically integrated Pure CBD Oil product company besides CANB?
This is why CANB is a great stock to own before the FDA announces Enforcement Discretion for Pure CBD products
Here is a closer look at what Enforcement Discretion for Pure CBD products would mean for these products:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152094460
Now getting back to the question of CBD formulation and the difference between Pure CBD products, Full Spectrum CBD products and Broad Spectrum CBD products
When people say “CBD” and think about OTC products, there are 3 possible options that come to mind in terms of formulation
Before we talk about the different formulations, please understand that Hemp contains many different cannabinoids
Some say 50, others say 75, 100 or even 150+
We are only going to talk about the top 5 cannabinoids that show up in laboratory tests of hemp:
CBD
THC
CBG/CBN/CBC
Now, getting back to the most important topic of all — CBD formulations
A company has 3 basic options when it manufactures products containing CBD
1ST OPTION: “PURE CBD” OR “CBD ISOLATE”
1 CANNABINOID
CBD is CBD, right
It is often referred to as CBD Isolate
Isolate meaning the CBD is isolated from the other cannabinoids
There is Pure CBD and nothing else
A variety of different oils and fluids are typically used as solvents
Terpenes are federally legal and can be utilized to create the entourage effect
2ND OPTION: “FULL SPECTRUM CBD” OR “FULL SPECTRUM HEMP EXTRACT”
5 CANNABINOIDS
This is CBD + THC + CBG/CBN/CBC
There is no isolation or purification of the CBD here
CBD exists in its native form alongside 4 other cannabinoids (there are many more cannabinoids actually present, these are just the top 5 by concentration)
A variety of different oils and fluids are typically used as solvents
3RD OPTION: “BROAD SPECTRUM CBD”
4 CANNABINOIDS
This is CBD + CBG/CBN/CBC
The THC has been removed
In order to make this formulation, CBD is first isolated from everything else
After the THC has been removed, the CBD Isolate is then mixed back in with CBG/CBN/CBC
A variety of different oils and fluids are typically used as solvents
With this background information in mind, please feel free to read why I believe the FDA will choose Pure CBD (CBD Isolate) as the first CBD formulation to obtain federal permission to be placed into the food supply and dietary supplements, published on July 25th:
AN FDA-CENTRIC CANNABINOID-BASED PARADIGM FOR CBD PRODUCT REGULATION
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150123700
Hard evidence supporting this Pure CBD thesis began pouring in shortly thereafter
5 days after I published my framework, on July 30th Dr. Gottlieb wrote a piece in the Washington Post which strongly suggested that Purified CBD will become the 1st CBD formulation permitted by the FDA:
PROOF THAT THE FDA WILL APPROVE CANB’S CBD OIL PRODUCTS
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150292900
On August 9th, Dr. Gottlieb appeared on CNBC and added to the evidence that Pure CBD will receive the green light from the FDA:
CNBC VIDEO: PURIFIED CBD WILL BE FEDERALLY PERMITTED BY FDA
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150438663
If you only have 15 seconds of time, watch Dr. Gottlieb rule out THC in CBD products right here:
On August 7th, Dr. Gottlieb appeared on C-SPAN and spoke about the timeframe for Pure CBD to be given the FDA’s blessing as “Immediate” — here’s a 90 second clip:
“IMMEDIATE” FDA APPROVAL FOR PURE CBD IN THE FOOD SUPPLY AND DIETARY SUPPLEMENTS
https://www.c-span.org/video/?c4813527/user-clip-dr-gottlieb-the-fda-approve-cbd-isolate-immediately
On 9/12/19 during a quarterly conference call, Aurora Cannabis CEO Terry Booth predicted the FDA will choose CBD Isolate as the first formulation to attain approval for national sales:
AURORA CEO PREDICTS FDA WILL CHOOSE CBD ISOLATE
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151289189
As the only publicly traded company in America growing and processing hemp for CBD Isolate and selling a full lineup of Pure CBD Oil products using terpenes to create the entourage effect, CANB is best positioned to deliver a windfall to its investors due to the FDA permitting the national sales of Pure CBD products only
Mile High Labs and Medterra are two of the biggest CBD Isolate processors and Pure CBD Oil products companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to a fully vertically integrated Pure CBD Oil product company besides CANB?
Sleek
SLEEKSCAPE’S GRAND SALAMI FOR 2020 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE’S-2020-HEMP-CBD-&-MARIJUANA-MANIA-GRAND-SALAMI-PART-II-31243/
Recent CANB News
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million • InvestorsHub NewsWire • 03/11/2024 12:34:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:02:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:52:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 06:08:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:18:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 02:44:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 06:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:57:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:12:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:41:28 PM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM